Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHADE: High Dose Vitamin D for COVID-19
NCT04459247Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jun 2020
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of vitamin d in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: SARS-CoV-2 Virus Negativity at 21 days. Started Jun 2020; status: completed.
02
Drugs
vitamin d
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04459247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04459247.